 |
|
Clinical studies of dapagliflozin in pediatric patients: a rapid review
Paige M. Grube, Robert D. Beckett
Ann Pediatr Endocrinol Metab. 2022;27(4):265-272. Published online 2022 Dec 31 DOI: https://doi.org/10.6065/apem.2244166.083
|
|
Citations to this article as recorded by
 The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper
Faical Jarraya, Abdou Niang, Hussein Bagha, Elliot Koranteng Tannor, Ernest Kiswaya Sumaili, Davy Ip Min Wan, Mogamat-Yazied Chothia, Yewondwossen Tadesse Mengistu, Francois Folefack Kaze, Ifeoma Isabella Ulasi, Saraladevi Naicker, Mohamed Hany Hafez, Kou
Kidney International Reports.2024; 9(3): 526. CrossRef Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review
Sebastiano A. G. Lava, Craig Laurence, Alessandro Di Deo, Nicole Sekarski, Michael Burch, Oscar Della Pasqua
Pediatric Drugs.2024;[Epub] CrossRef Renal Biomarkers and Novel Therapies in Pediatric Nephrology: From Chronic Kidney Disease to Renal Transplantation
Valeria Chirico, Roberto Chimenz
Journal of Clinical Medicine.2023; 12(11): 3810. CrossRef
|